GPT and Hyperbilirubinemia: After four weeks of treatment, AST, and ALT normalized (AST: 40 U/L and ALT: 35 U/L), and hyperbilirubinemia decreased to grade 1 (total and direct bilirubin: 1.46 mg/dL and 0.61 mg/dL, respectively).